Allogene Therapeutics Inc... (ALLO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.85
-0.07 (-3.65%)
At close: Jan 15, 2025, 2:44 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | 95.00K | 243.00K | 38.49M | n/a | n/a | n/a | n/a |
Cost of Revenue | 242.91M | 16.73M | 13.06M | 11.54M | 5.03M | 1.50M | n/a |
Gross Profit | -242.82M | -16.48M | 25.42M | -11.54M | -5.03M | -1.50M | n/a |
Operating Income | -327.74M | -335.45M | -255.79M | -258.24M | -202.01M | -192.84M | -2.00K |
Interest Income | 18.31M | 4.57M | 1.71M | 9.16M | 17.35M | 5.79M | n/a |
Pretax Income | -327.26M | -332.63M | -257.00M | -250.22M | -184.93M | -211.62M | -2.00K |
Net Income | -327.26M | -329.81M | -244.84M | -233.47M | -184.59M | -211.50M | -2.00K |
Selling & General & Admin | 71.67M | 79.31M | 74.11M | 65.26M | 57.47M | 40.98M | 2.00K |
Research & Development | 242.91M | 256.39M | 220.18M | 192.99M | 144.53M | 151.86M | n/a |
Other Expenses | 13.24M | -1.75M | -2.93M | -1.14M | -268.00K | -21.21M | n/a |
Operating Expenses | 327.83M | 335.69M | 294.28M | 258.24M | 202.01M | 192.84M | 2.00K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 3.36M | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -22.00K |
Cost & Expenses | 327.83M | 335.69M | 294.28M | 258.24M | 202.01M | 192.84M | 2.00K |
Income Tax | n/a | -2.82M | -12.17M | -16.75M | -331.00K | -117.00K | -24.00K |
Shares Outstanding (Basic) | 156.93M | 143.15M | 135.82M | 120.37M | 101.06M | 28.95M | 117.93M |
Shares Outstanding (Diluted) | 156.93M | 143.15M | 135.82M | 120.37M | 101.06M | 28.95M | 117.93M |
EPS (Basic) | -2.09 | -2.3 | -1.8 | -1.94 | -1.83 | -7.31 | n/a |
EPS (Diluted) | -2.09 | -2.3 | -1.8 | -1.94 | -1.83 | -7.31 | n/a |
EBITDA | -300.29M | -321.24M | -169.74M | -250.81M | -179.90M | -206.76M | 22.00K |
Depreciation & Amortization | 14.20M | 14.29M | 10.45M | 11.54M | 5.03M | 1.50M | 24.00K |